| Acquired by | IntegenX |
| Date | 2/11 |
| Website | genvault.com |
| Category | BioTech |
| Phone | 760-268-5200 |
| info@genvault.com | |
| Employees | |
| Description | Biosamples |
| TOTAL | $31M |
| FUNDING TOTAL | $31M |
| Venture Round, 4/07 QuestMark Partners Domain Associates | $18M |
| Series C, 6/08 QuestMark Partners Montagu Newhall Associates Domain Associates Cross Creek Capital | $13M |
GenVault is dedicated to stabilizing biosamples and to the integration of biosample transport, storage and retrieval, in a way that meshes seamlessly with day-to-day lab operations: thus simplifying sample sharing for customers in genomic medicine, discovery and identification. Today, we are empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies, to more fully leverage the rapidly growing genomics industry. GenVault’s proprietary dry-state storage platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Currently work is proceeding on equivalent storage technologies for protein and RNA.
The need for such sample management solutions is growing at an exponential rate, as more and more samples are collected worldwide for disease diagnosis, research, identification and criminal investigations
